Literature DB >> 3512825

Development of new drugs in man: a review.

I B Davies, I M Grind, A Pottage, P Turner.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3512825      PMCID: PMC1290191          DOI: 10.1177/014107688607900210

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  19 in total

1.  Can postmarketing surveillance help to effect optimal drug therapy?

Authors:  B L Strom; K L Melmon
Journal:  JAMA       Date:  1979-11-30       Impact factor: 56.272

2.  For the first time in man.

Authors:  B Blackwell; B L Martz
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

3.  Clinical pharmacology. Adverse drug interactions.

Authors:  J K Aronson; D G Grahame-Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-24

4.  Clinical pharmacology. Drug monitoring.

Authors:  D C Moir
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

5.  Current issues in the design and interpretation of clinical trials.

Authors:  S J Pocock
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-05

6.  Placebos and other comparative treatments.

Authors:  C R Joyce
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

7.  Noninvasive assessment of the cardiovascular effects of psychotropic drugs.

Authors:  S J Warrington
Journal:  J Clin Psychiatry       Date:  1982-05       Impact factor: 4.384

Review 8.  The importance of clinical pharmacology in drug development.

Authors:  C F George
Journal:  Clin Sci (Lond)       Date:  1981-03       Impact factor: 6.124

9.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review.

Authors:  A H Glassman; J T Bigger
Journal:  Arch Gen Psychiatry       Date:  1981-07

10.  Sample size for short-term trials of antihypertensive drugs.

Authors:  S Freestone; J H Silas; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.